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Abstract
Background: Two-photon laser scanning microscopy (TPLSM) has become a powerful tool in the visualization of
immune cell dynamics and cellular communication within the complex biological networks of the inflamed central
nervous system (CNS). Whereas many previous studies mainly focused on the role of effector or effector memory T
cells, the role of naïve T cells as possible key players in immune regulation directly in the CNS is still highly debated.
Methods: We applied ex vivo and intravital TPLSM to investigate migratory pathways of naïve T cells in the
inflamed and non-inflamed CNS. MACS-sorted naïve CD4+ T cells were either applied on healthy CNS slices or
intravenously injected into RAG1 -/- mice, which were affected by experimental autoimmune encephalomyelitis
(EAE). We further checked for the generation of second harmonic generation (SHG) signals produced by
extracellular matrix (ECM) structures.
Results: By applying TPLSM on living brain slices we could show that the migratory capacity of activated CD4+ T
cells is not strongly influenced by antigen specificity and is independent of regulatory or effector T cell phenotype.
Naïve T cells, however, cannot find sufficient migratory signals in healthy, non-inflamed CNS parenchyma since
they only showed stationary behaviour in this context. This is in contrast to the high motility of naïve CD4+ T cells
in lymphoid organs. We observed a highly motile migration pattern for naïve T cells as compared to effector CD4+
T cells in inflamed brain tissue of living EAE-affected mice. Interestingly, in the inflamed CNS we could detect
reticular structures by their SHG signal which partially co-localises with naïve CD4+ T cell tracks.
Conclusions: The activation status rather than antigen specificity or regulatory phenotype is the central
requirement for CD4+ T cell migration within healthy CNS tissue. However, under inflammatory conditions naïve
CD4+ T cells can get access to CNS parenchyma and partially migrate along inflammation-induced extracellular
SHG structures, which are similar to those seen in lymphoid organs. These SHG structures apparently provide
essential migratory signals for naïve CD4+ T cells within the diseased CNS.
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1. Background
In the last 10 years, two-photon laser scanning micro-
scopy (TPLSM) has revealed the dynamic nature of
immune cells within living lymphoid and target organs
[1-6]. This has led not only to a better understanding of
generation and priming of many immune cells, but also
of the basics of immune regulation.
Using TPLSM, we previously showed that activated
CD4+ effector T cells are attracted to the CNS’s perivas-
cular space and reveal a CXCR4 dependent and vessel-
associated migration pattern, suggesting this compart-
ment is highly relevant for autoimmunity and immunor-
egulation [3,7]. While previous studies of ours as well as
other studies mainly concentrated on T cells in their
effector or effector-memory state, in the current study
* Correspondence: helena.radbruch@charite.de
6Labor für Molekulare Psychiatrie, Charité and Berlin-Brandenburg School for
Regenerative Therapies (BSRT), Charité Universitätsmedizin Berlin, Charitéplatz
1, 10117 Berlin, Germany
Full list of author information is available at the end of the article
Herz et al. Journal of Neuroinflammation 2011, 8:131
http://www.jneuroinflammation.com/content/8/1/131
JOURNAL OF 
NEUROINFLAMMATION
© 2011 Herz et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.we focused on the behaviour of naïve and regulatory T
cells.
Activated and memory T cells express adhesion mole-
cules, chemokine receptors and integrins that enable them
to cross the blood brain barrier to carry out immune sur-
veillance of the CNS [7]. Adversely, naïve T cells which do
not express essential proteolytic enzymes (e.g. matrix
metalloproteinases) and adhesion ligands (e.g. LFA-1 and
VLA-4), were thought to circulate only between the blood,
lymph and secondary lymphoid organs. However, flow
cytometry experiments showed that naïve T cells can
indeed be found in the healthy, non-inflamed CNS [8,9].
This is also the case for other non-lymphoid tissues
including the pancreas, intestine, lung, liver, kidney, skin
and testis, where it is thought that this circulation is part
of the normal migratory behaviour of naïve T cells [8].
During CNS- inflammation adhesion ligands (i.e. ICAM-1
and VCAM) facilitate T cell recruitment to the CNS
[10-12], and they only get activated when they encounter
their antigen in the CNS [13].
Naïve T cells could therefore be potential players in
CNS immunoregulation and fulfil an important role
both in physiological immune surveillance and in patho-
logical autoimmune processes, such as those which
occur during Multiple Sclerosis or experimental autoim-
mune encephalomyelitis (EAE). However, this raises the
question how these T cells can migrate through struc-
tures of normal tissue in the absence of inflammatory
conditions. This is particularly unclear in the CNS in
which there is an intricate architecture of neurons, mye-
linated axons, oligodendrocytes, astrocytes and micro-
glia. Furthermore, the CNS includes a highly complex,
extracellular matrix which provides both structural sta-
bility and supports homeostasis of the cellular compo-
nents. Conventional histological examinations offer
insights into these questions, but lack the capacity to
directly address kinetics, dynamics and functional rele-
vance of T cell trafficking.
Hence, in the current study we applied intravital
TPLSM to investigate migratory pathways of naïve T
cells in healthy and inflamed CNS.
2. Methods
2.1. Mice
C57BL/6 mice and C57BL/6 pups were purchased from
Charles River (Germany). b-actin-EGFP transgenic
C57BL/6 (003291, C57BL/6-Tg(ACTB-EGFP)1Osb/J),
OT-2 (C57BL/6-Tg(TcraTcrb)425Cbn) transgenic mice
and RAG1 -/- transgenic C57Bl/6 (002216, B6.129S7-
Rag1tm1Mom/J) were originally obtained from The
Jackson Laboratory (Maine, USA), bred under SPF con-
ditions at the central animal facility of the Charité -
University Medicine Berlin (FEM), and kept in-house for
experiments in IVC (individually ventilated cages).
C57BL/6 OT2 mice, C57BL/6 2d2 TCR [14] transgenic
mice (kindly provided by A. Waismann), C57BL/6
Rosa26 tdRFP ("ΔNeo-flip”)mice [15], obtained from H.J.
Fehling, or C57BL/6 b-actin-EGFP transgenic mice were
intercrossed to generate C57BL/6 OT2 tdRFP, C57BL/6
2d2 tdRFP mice and C57BL/6 OT2 EGFP mice, respec-
tively. C57BL/6 Thy1-21 EGFP [16] mice were kindly
provided by P. Caroni, C57BL/6 Thy1.1 CerTN L15
mice were kindly provided by O.Griesbeck [17] C57BL/6
Foxp3 EGFP mice were kindly provided by B. and M.
Malissen.
All animal experiments were conducted according to
the German Animal Protection Law, were approved by
the appropriate state committees for animal welfare
(LAGeSo, Landesamt für Gesundheit und Soziales) and
were performed in accordance with current guidelines
and regulations.
2.2. Cell culture
Mice (6-10 weeks old) were sacrificed and spleen cells
were isolated as described before [3]. For OT-2 Th2
cells splenocytes were cultured in 3 × 10
6/ml cell cul-
ture medium (RPMI 1640 supplemented with 2 mM L-
glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin,
and 10% fetal calf serum), and stimulated with the
respective ovalbumin (OVA) peptide (0.3 μMO V A 323-
339; Pepceuticals, UK). Differentiation towards a Th2
phenotype of OT-2 cells was achieved by the addition of
200U/ml IL-4, 5 μg/ml anti-IL-12 (C17.8) and anti-IFN-
g (AN18.17.24). C57BL/6 Th1 cells were generated from
CD4+ sorted spleen and lymph node cells (MACS
®)o f
C57BL/6 mice by polyclonal activation by 1 μg/ml plate-
bound antiCD3/antiCD28 in the presence of 5 ng/ml IL-
12 and 5 μg/ml anti-IL-4 (11B11). Antigen specific and
polyclonal effector T cells were restimulated every 7
days by irradiated syngenic CD90-depleted (MACS
®)
APCs or antiCD3/antiCD28, respectively. C57BL/6
Foxp3 expressing regulatory T cells were isolated either
by MACS
®sort for CD4, CD25 and CD62L or by FACS
for Foxp3EGFP and CD62L. Cells were polyclonally acti-
vated by plate-bound antiCD3/antiCD28 (3/10) in round
bottom 96 well plates in the presence of 2000 U IL-2.
IL-10 producing Ovalbumin- or MOG-specific regula-
tory T cells were generated according to the protocol by
Barrat et al.[18]. Briefly, naïve CD4+CD62L+T cells
were stimulated with irradiated syngenic CD90depleted
splenic APCs (MACS
®)a n d0 . 3μMO V A 323-339 or 12,5
μg/ml MOG35-55 peptide in the presence of 40 nM Vita-
min D3 and 100 nM Dexamethasone and 5 μg/ml anti-
IL-12 (C17.8), anti-IFN-g (AN18.17.24) and anti-IL 4
(11B11). Restimulation was done on day 7 with anti-
CD3/anti-CD28. All analysed T cell subsets were stimu-
lated for 3-7 days prior to hippocampal brain slice co-
culture experiments. For characterization of T cell
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short term stimulated (4 h antiCD3/antiCD28) T cells
on day 4-7 in order to analyse cytokine and Foxp3
expression by flow cytometry.
For T cells of naïve phenotype spleen and lymph node
cells of OT2, OT2 EGFP or OT2 tdRFP mice were
MACS
®-sorted for CD4 and CD62L and used for i.v.
injection for lymph node and intravital imaging of the
brain stem or for application onto hippocampal brain
slices.
2.3. Experimental Autoimmune Encephalomyelitis
For adoptive transfer EAE, spleen cells from C57BL/6
2d2.tdRFP or C57BL/6 2d2.EGFP mice were isolated
and stimulated as previously described [19]. Three days
after the second restimulation, 5 × 10
6 2d2.tdRF TH17
or 2d2.EGFP TH17 cells were transferred intravenously
into C57BL/6 RAG1
-/-. Cytokine expression was checked
on restimulation and before transfer. Mice were checked
for clinical symptoms daily and signs of conventional
EAE were translated into clinical score as follows: 0, no
detectable signs of EAE; 0.5, tail weakness; 1, complete
tail paralysis; 2, partial hind limb paralysis; 2.5, unilateral
complete hind limb paralysis; 3, complete bilateral hind
limb paralysis; 3.5, complete hind limb paralysis and
partial forelimb paralysis; 4, total paralysis of forelimbs
and hind limbs (mice with a score above 3.5 to be
killed); 5, death. The severity of atypical EAE was trans-
lated as: grade 1, tail paralysis, hunched appearance;
grade 2, ataxia, scruffy coat; grade 3, head tilt, hypersen-
sitivity, spasticity or knuckling; grade 4, severe proprio-
ception defects; grade 5, moribund.
For intravital imaging of naïve T cells MACS
®-sorted
naïve OT2 EGFP or OT2 tdRFP cells were co-trans-
ferred intravenously 12-24 hours before TPLSM or were
locally applied on the imaging field at the peak of dis-
ease (score 2.5-3.5).
2.4. Two-photon laser scanning microscopy
T cells and vessels were visualised by a two-photon laser
scanning system (LaVision BioTec, Bielefeld) as
described before [20] with dual NIR (850 nm) and IR
(1,110 nm) excitation. XYZ-stacks were typically col-
lected within a scan field of 300 × 300 μm at 512 × 512
pixel resolution and a z-plane distance of 2 μm at a fre-
quency of 400 or 800 Hz. Applied laser powers ranged
from 2-6 mW at the specimen’s surface.
2.5. Brain slice T cell co-culture
Preparation of brain slices was performed as previously
described [3] and allowed to recover for at least 45 min
at room temperature prior to transfer to a heated and
with aerated artificial cerebrospinal fluid (ACSF) per-
fused Luigs & Neumann slice chamber (37°C). T cells, if
not expressing EGFP or tdRFP, were stained with cell-
tracker Orange CMTMR (Invitrogen, Germany),
pipetted upon the slice and allowed to invade the slice
for about 30 - 60 min before image acquisition.
2.6. Anaesthesia and preparation of imaging field for
intravital imaging
Mice were anaesthetized using 1.5% isoflurane (Abott)
in oxygen/nitrous oxide (1:2) with a facemask. They
were then tracheotomized and continuously respirated
with a Harvard Apparatus Advanced Safety Respirator
(Hugo Sachs, Germany). For the brainstem imaging, the
anaesthetized animal was transferred to a custom-built
microscopy table and fixed in a hanging position. The
preparation of the imaging field was performed as pre-
viously described [3].
2.7. Lymph node preparation for TPLSM
Lymph node preparation was performed as previously
described [20]. In brief, 8-96 hours after intravenous
injection of naïve OT2 EG F Po rO T 2t d R F PTc e l l s ,
popliteal lymph nodes were removed, glued onto a cov-
erslip and placed into a heated chamber at 36°C, super-
fused RPMI medium without phenol red bubbled with
95%O2/5%CO2. Naïve T cell migration was visualised
up to 130 μm beneath the surface using the same
TPLSM setup as described above.
2.8. Data analysis
Cell recognition, movement tracking and 3D presenta-
tion were performed with Volocity (Improvision, Ger-
many) and tracks with durations > 5 min. were included
in the analysis. Average cell velocity was calculated with
Volocity. The co-localisation area was calculated with
Volocity as previously described [19]. To discriminate
short/transient (random) contacts from long-lasting
(most probably non-random) interactions, we defined
contacts which last longer than 5 min as ‘long-lasting’.
These interactions were further differentiated into slow/
static (velocity < 0.04 μm/s) and dynamic (velocity >
0.04 μm/s) contacts. In order to exclude the SHG signal
which is detected with the same detector as EGFP in
our setup, we increased the signal threshold so that only
EGFP expressing cells (without any SHG signal) were
automatically identified and tracked by the software. For
angle comparison between cell trajectories and vessel
structures and for vessel distance measurements at the
end of the track, cell-tracking data from Volocity was
further processed in MATLAB as described previously
[3]. For each track, a vector between origin and end-
point was calculated in a two-dimensional angle and the
distance between the cell-tracking vector and the vector
representing the vessel was calculated using standard
linear algebra. Statistical analysis was carried out with
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GraphPad Prism 4 (Graphpad Software, USA). Results
are shown as individual data points; in addition, mean ±
SD summarize collective data from performed experi-
ments. To test for statistical significance of differences
between two T cell subpopulations, the non-parametric
Mann-Whitney-test was performed for more than two
groups Kruskal Wallis test with Dunn’sm u l t i p l ec o m -
parison test as post test was performed.
3. Results
3.1. Intravital imaging of the inflamed CNS of living mice
reveals distinct migration pattern of naïve T lymphocytes
To observe naïve T cell migration under inflammatory
circumstances in the CNS, we first performed flow
cytometry analysis on brain-derived immune cells after
transfer of naïve T cells, which are characterized by high
CD62L and low CD69, CD25 and CD44 expression (Fig-
u r e1 A ) ,i n t oE A Ea f f e c t e dR a g1 - / -m i c e .F o rd i s e a s e
induction we transferred in vitro generated encephalito-
genic 2d2 CD4+ TH17 cells (with transgenic T cell
receptor specific for Myelin Oligodendrocyte Glycopro-
tein (MOG)). Some of the injected naïve T cells could
be detected in the CNS but the cell number was too
low to analyse activation markers and CD62L expression
(data not shown). Therefore we used intravital TPLSM
in the brainstem to record their behaviour. Using this
approach it was possible to find naïve T cells up to 150
μm deep in the CNS parenchyma in EAE and to track
their migration (Figure 1B). We used T cells with a
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Figure 1 Intravital imaging reveals high motility of naïve CD4+ T cells in the inflamed CNS. Naïve OT2 EGFP T cells were intravenously
injected into EAE affected mice at the peak of disease (clinical score 2.5) or locally applied onto the imaging field. Intravital TPLSM on the brain
stem of these mice was performed 12 - 24 hours after naïve T cell injection or 30 minutes after local application. Adoptive EAE was induced by
transfer of in vitro generated encephalitogenic 2d2 Th17 T cells into C57BL/6 RAG1-/- mice. (A) T cell phenotype of MACS isolated naïve T cells
was confirmed by FACS analysis prior to experiments. Surface antigen expression of CD62L, CD25, CD69 and CD44 was determined on CD4+
lymphocytes. (B) A representative time lapse series derived from intravital TPLSM demonstrates rapid movement of naïve T cells deep in CNS
tissue (100-150 μm). Two cell tracks are shown exemplarily by white arrows. For further details see also Additional File 1 (Scale bar: 10 μm.). (C)
Cell track velocities of naïve OT2 (N = 212) and effector 2d2 Th17 (N = 87) cells at the peak of disease in the inflamed CNS were quantified. The
mean track velocities from 4 independent experiments are shown (± SD). (D) Contacts (arrowheads) between encephalitogenic 2d2 Th17
effector T cells (EGFP,green) and naïve OT2 (tdRFP red) could be observed during intravital TPLSM, as revealed by the reconstructed 3D time
lapse series (80-110 μm). These interactions were mainly short and random like (open arrowhead) although some static long-lasting contacts
(filled arrowhead) could be also detected. (E) To quantify effector-naïve T cell interactions we analyse the co-localisation area of EGFP and tdRFP
as previously described [19]. We discriminated short (random) contacts (< 5 min) from long-lasting (most probably non-random) interactions (≥
5 min) and observed that 81% ± 14 formed short interactions with effector T cells (white bar) and 19% ± 14 (gray bar) formed long-lasting
interactions. Data are shwon as percentage of all contacts from two independent experiments (± SD).
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to limit antigen specific activation on their way to and
within the CNS. To further minimize activation, our
timepoint of investigation was shortly after transfer (12
h for IV and 30 min for local application). Whereas we
previously observed no lymphocytes in healthy mice
deep in the CNS parenchyma we could detect some
sporadic cells in the perivascular space [3]. However,
during EAE naïve T cells were able to invade the par-
enchyma after local application on the brainstem or to
cross the corrupted blood brain barrier after IV transfer
and to move rapidly (Figure 1B, Additional File 1)
resulting in a mean track velocity of 0.13 ± 0.05 μm/sec
(± SD; N = 212) which was similar to that of encephali-
togenic 2d2 CD4+ TH17 effector cells with 0.12 ± 0.06
μm/sec (±SD; N = 87) (Figure 1C). The dynamic inter-
action between both cell types was examined by co-loca-
lisation analysis as previously described [19]. We
discriminated between short (random) contacts and
long-lasting (most probably non-random). On their way
through the parenchyma 19% of all contacts were of
long-lasting nature whereas the majority (81 ± 14%) of
the naïve-effector T cell interactions was short and ran-
dom (Figure 1D/E).
3.2. Naïve CD4+ T cells do not get sufficient migratory
signals in non-inflamed CNS tissue
As it was not possible to investigate the behaviour of
naïve CD4+ T cells in healthy living anaesthetized mice
due to the low frequency of lymphocytes after IV trans-
fer [21], we circumvented the blood brain barrier and
applied naive CD4 T cells on the brain stem of healthy
living anaesthetized mice. The cells remained stucked
on the surface or were flushed away with the perfusion
(Additional File 2). We further co-incubated naïve T
cells with brain tissue cultured in artificial cerebrospinal
fluid (ACSF). These CNS slices have been shown to
retain a middle layer which consists of intact in vivo-like
CNS in murine brain cultures [22]. Naïve CD4+ T cells
were labeled with the Celltracker Orange 5-(and-6)-(4-
chloromethyl(benzoyl)amino) tetramethylrhodamine
(CMTMR) if they were not transgenic for tdRFP or
EGFP, and consecutively co-incubated with a living
brain slice in which the vasculature had been high-
lighted by previous IV injection of FITC- or rhodamine-
dextran. Independent of the need to transmigrate
through the blood brain barrier, these cells showed a
nearly stationary behaviour. The cell tracks were short
and the cells seemed more or less trapped in their posi-
tion on the slice surface after application on the non-
inflamed CNS tissue (Figure 2A). This was quantified by
a significantly lower mean track velocity with 0.056 ±
0.03 μm/sec (± SD; N = 86) as compared to activated
CD4+ T cells (**p < 0.01). Furthermore the significantly
reduced displacement rate of 0.019 ± 0.015 μm/sec (±
SD) shows that they move on their place and do not
invade the parenchyma (***p < 0.01) (Figure 2B).
3.3. Activated T helper cells infiltrate non-inflamed brain
tissue independent of antigen specificity and phenotype
and show a perivascular compartmentalisation
The stationary behaviour of naïve CD4+ T cells, as
described above, is clearly a contrast to the migration
pattern of activated CD4+ TH1 and CD4+ TH2 effector
cells. We previously showed that CD4+ antigen specific,
highly-activated and differentiated effector T cell lines
show a vessel-associated movement pattern [3]. We
wanted to check whether antigen specificity or regula-
tory phenotype would influence T cell migration. There-
fore we performed T cell brain slice co-culture
experiments as described above exemplarily for activated
antigen specific (OT2 or 2d2) IL-10-producing regula-
tory and antigen specific (OT2) effector CD4+ TH2
cells as well as for polyclonally-activated Foxp3 T regu-
latory and CD4+ TH1 effector cells (Figure 3A). After
an initial invasion period, the potential of tissue penetra-
tion was evident for all analysed activated T cell subsets
as visualised by time lapse TPLSM. Furthermore, the
migration pattern was similar in all investigated CD4+ T
cell subtypes. The mean angle between vessel and cell
trajectory vectors was similar in all investigated sub-
groups (Figure 3B, Figure 3C). The vessel-associated
movement of CD4+ T cells in contrast to CD8+ T cells
[3] seems also to be important for regulatory T cell sub-
types independent of antigen specificity and underlines
the importance of the perivascular space for immunore-
gulation and autoimmunity. Activated CD4+ T cells of
regulatory phenotypes moved through non-inflamed
CNS tissue with 0.07 ± 0.04 μm/s (± SD) for antigen-
specific IL-10 producing regulatory T cells (N = 290)
and 0.08 ± 0.04 μm/s (± SD) for C57Bl/6 Foxp3 CD4+
T cells (N = 215). Activated effector T cell subsets also
revealed comparable mean track velocities, irrespective
of antigen specificity and phenotype with 0.07 ± 0.0 μm/
s (± SD) for OT2 Th2 (N = 290) and 0.07 ± 0.04 μm/s
(± SD) for C57BL/6 Th1 (N = 248) cells (Figure 2B).
3.4. Naïve CD4+ T cells reveal high motility in healthy
lymphoid organs
As control for the principle migratory capacity of naïve
CD4+ T cells we injected MACS
® sorted naïve OT2
cells intravenously into healthy mice and tracked their
migration pattern in the lymph node (Figure 4). To
check whether the cells were activated and primed after
transfer we performed FACS analysis on injected cells
and observed that these cells retain their CD62L
high and
CD69
low phenotype up to 4 days after transfer (Figure
4A). We performed our experiments within this time
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naïve T cells (Figure 4B). Cell tracking analysis of indivi-
dual T cells confirmed our qualitative observations, as
the mean track velocity with 0.17 ± 0.06 μm/sec (± SD;
N = 126) was similar to what was previously described
by others [2] (Figure 4C).
3.5. Naïve T cells partially migrate along inflammatory
induced reticular fibers in vivo
In lymphoid tissue it is known that naïve T cell motility
is directed by fibroblastic reticular cells and ECM struc-
tures which can be visualised by second harmonic gen-
eration (SHG) [23]. Interestingly, we observed similar
SHG signals which were generated by an optical para-
metric oscillator (OPO) at 1110 nm wavelength in the
inflamed CNS of EAE affected mice. Moreover, naïve T
cells partially moved along these structures (Figure 5A,
Additional File 3). In order to objectify our observation
we performed quantitative analysis for naïve T cell -
SHG co-localization (Figure 5B/C). This analysis
revealed that most of the contacts are short (81 ± 14%)
but there is also a population of naive T cells that show
long-lasting contacts with the reticular fiber network (19
± 14%). These interactions were further differentiated
into slow/static (velocity < 0.04 μm/s) and dynamic
(velocity > 0.04 μm/s) contacts. Interestingly, these long-
lasting contacts were due to migration associated co-
localisation, since their velocity was > 0.04 μm/s sup-
porting our qualitative observation that a distinct popu-
lation of naïve T cells partially migrate along these
inflammation induced fibers (Figure 5B/C).
The reticular fiber network was observed deep in the
parenchyma (up 100 μm) and thus could be distin-
guished from the arachnoidea covering the surface of
the brain stem parenchyma. Moreover, by visualisation
of the vasculature by IV Rhodamine-dextrane injection
prior to imaging we observed that in addition to the
vessel associated collagen network surrounding the very
close proximity of the vasculature further fiber tracts are
generated deep in the parenchyma itself (Figure 5D).
We could not detect these structures under healthy
conditions in the CNS parenchyma (Additional File 2).
However, intravital TPLSM on the brain stem of EAE
affected C57BL/6 Thy1.1 CerTN L15 mice which express
a FRET based calcium sensor, i.e. the Citrulin/Cerulean
FRET pair (based on YFP/CFP) in neurons and neuronal
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Figure 2 Naïve CD4+ T cells hardly infiltrate non-inflamed CNS tissue. MACS isolated CMTMR stained naïve T cells were co-incubated with
living hippocampal brain slices in order to visualise their migratory capacity. (A) 3D time lapse TPLSM revealed a nearly stationary behaviour of
naïve T lymphocytes. Cell tracking analysis of individual T cells confirmed these qualitative observations since the corresponding trajectory
vectors display almost no displacement of naïve T lymphocytes. (Scale bar: 110 μm). (B) Track velocities and displacement rates for naïve T cells
are compared with different activated T cell subsets (OT-2 Th2, OT-2/2d2 IL-10 reg T, C57BL6 Th1, C57BL6 Foxp3 Treg) using cell tracking analysis
for individual cells of 2-6 independent experiments (± SD). **p < 0.01, ***p < 0.001, Kruskal Wallis Test.
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guish the generated SHG signal due to wavelength spe-
cificity of SHG (1110 nm) and separated excitation of
Citrulin (850 nm). Using this approach we did not
observe any co-localisation with the neuronal structures.
In contrast, they appeared to cross the neuronal pro-
cesses orthogonally, as visualised by merging fluores-
cence images acquired at both excitation wavelengths
(Figure 5E).
4. Discussion
Unexpectedly, we observed a highly motile migration
pattern for naïve T cells similar to effector T cells in the
inflamed CNS of living EAE affected mice. However, we
could further show that even though naïve T cells have
migratory capacity in lymphoid organs and diseased
CNS, they cannot find sufficient migratory signals in
healthy non-inflamed CNS parenchyma since they only
showed stationary behaviour in this environment. Using
different experimental approaches, i.e. locally applied or
IV transferred naive T cells, we could detect highly
motile cells in the inflamed CNS parenchyma but no
migration in healthy tissue supporting the hypothesis
that the extend of inflammation is the crucial factor
determining the possibility for naive T cells migration in
the CNS parenchyma. Interestingly, in the inflamed
CNS we could detect reticular structures by their SHG
signal which was not detected in the non-inflamed CNS.
These structures resemble those present in lymphoid
tissues, suggesting that these inflammation-induced
structures might provide the chemotactic signals needed
for the naïve T cells to migrate within the diseased CNS.
00 min 05 min 10 min 20 min 25 min
00 min 05 min 10 min 15 min 20 min
00 min 05 min 10 min 15 min 20 min
00 min 05 min 10 min 15 min 20 min
A
B OT2 Th2 OT2 IL-10 reg T
C57BL/6 Th1 C57BL/6 Foxp3 Treg
IFN      IL-4
CD4      FSC
IL-4
IFN
IL-10
Foxp3




C
5
7
B
L
/
6
 
F
o
x
p
3
 
T
r
e
g
O
T
2
 
T
L
-
1
0
 
r
e
g
 
T
O
T
2
 
T
h
2
C
5
7
B
L
/
6
 
 
T
h
1
C
OT2 Th2          OT2 IL-10 reg T       C57Bl6 Th1    C57Bl6 Foxp3 Treg  
ns
Figure 3 Activated regulatory and effector CD4+ T cells move rapidly in healthy CNS tissue independent of antigen specificity. T cell
brain slice co-culture experiments were performed for activated antigen-specific IL-10 producing regulatory and effector CD4+ TH2 cells as well
as for polyclonally activated Foxp3 regulatory and effector CD4+ TH1 cells. (A) T cell subsets were characterized by intracellular staining of
typically expressed molecules for each cell type. For detection of interleukins, T cells were stimulated by aCD3/aCD28 (1 μg/ml) prior to staining.
(B) Movement patterns of polyclonally and antigen-specific activated regulatory and effector T cells were analysed by time lapse TPLSM at 80-
130 μm depth after an initial invasion period of 30-45 min. For each series, migratory routes of two exemplary cells (white) are represented by
white arrows. (C) Vector vessel angels of individual cell tracks of different activated T cell subsets (OT-2 Th2, OT-2/2d2 IL-10 producing regulatory
T cells, C57BL6 Th1, C57BL6 Foxp3 Treg) were calculated using cell tracking analysis for individual cells of 2-6 independent experiments per
group (± SD). ns: not significant, Kruskal Wallis Test.
Herz et al. Journal of Neuroinflammation 2011, 8:131
http://www.jneuroinflammation.com/content/8/1/131
Page 7 of 12Little is known concerning the behaviour of naïve T
cells in non-lymphoid organs under both homeostatic
and inflammatory conditions in general. Regarding the
CNS even less is known and most of the data are
derived from flow cytometry studies of cells isolated
from CNS tissue [8,9,13,24,25] or cerebrospinal fluid
[26] and give contradictory results. Using an in vivo
staining method, a recent study did not detect naïve
CD4+ T cells in the brain at 4 days after transfer of
naïve T cells [24]. In contrast experiments using an
inverse transfer model (encephalitogenic cells into OVA
specific T cell receptor transgenic mice) show that naïve
endogenous T cells occur in parallel with activated
encephalitogenic T cells but keep a resting phenotype
unless they recognize their antigen in the CNS [13].
Similarly, McMahon et al. could only detect naïve PLP
specific T cells in PLP immunized mice in contrast to
OVA immunized controls. This supposes that naïve T
cells can only enter the CNS if they get locally activated
[25].
B u ti no u rs t u d yw ec o u l df i n dn a ï v eO V As p e c i f i c
CD4+ T cells in the inflamed CNS and using intravital
TPLSM we could further show for the first time that
naïve CD4+ T cells can indeed migrate rapidly through
the CNS parenchyma, comparable to the way they move
in lymphoid tissue. Due to the low frequency of naïve
CD4 T cells compared to effector Th17 cells in the
inflamed parenchyma it could be possible that they are
not detected by flow cytometry after isolation. Therefore
TPLSM could be used as complementary technique to
analyse rare cell migration and further allows the inves-
tigation of dynamics.
The mean track velocity of naïve T cells was similar to
the velocity of Th17 effector T cells. However, it
remains unclear what role naïve T-cells play in the
CNS. In MS naïve T cells are found in the cerebrospinal
fluid during relapses [26] and the experiments from
Brabb et al. support a possible function for the develop-
ment of tolerance [9]: Using MBP (myelin basic pro-
tein)-recognizing T-cell receptor transgenic mice, they
showed that naïve MBP-specific T cells isolated from
t h eb r a i nd i dn o ts h o wa n yr e a c t i v i t yf o rM B Pin vitro.
On the other hand, MBP-specific naïve T cells from the
periphery did react to MBP. Although we did not inves-
tigate the direct impact of naïve CD4+ T cells on func-
tion and behaviour of encephalitogenic T cells within
the inflamed brain, our observation of direct contacts
between naïve T cells and encephalitogenic T cells
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Figure 4 High motility of naïve CD4+ T cells in healthy lymphoid tissue.M A C S
® sorted OT2 tdRFP expressing CD4+ naïve T cells were
intravenously injected into healthy C57BL/6 RAG 1 -/- mice in order to perform time lapse TPLSM on popliteal lymph nodes at 8 - 96 hours after
transfer. (A) Injected OT2 tdRFP cells were isolated from lymph nodes of C57BL/6 OT2 tdRFP mice and subjected to FACS analysis to measure
surface expression of CD62L, CD25, and CD44 at 96 hours after transfer. Dot Plots reveal analysis on CD4+ tdRFP positive lymphocytes. (B) High
motility of naïve T lymphocytes in lymph nodes is revealed by trajectory vector blots derived from cell tracking analysis of time lapse TPLSM at
24 hours after transfer (left). Each vector represents displacement of individual cells for an imaging period of 30 min (one image every minute)
relative to their starting position. A corresponding time lapse series of naïve cell migration is shown on the right. The dashed arrow represents
migration of one single cell exemplarily. (C) Quantification of naïve CD4+ T cell movement in isolated lymph nodes. The mean track velocity is
0.16 ± 0.06 μm/sec (± SD, N = 73).
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Page 8 of 12suggests a possible direct impact. It remains to be clari-
fied whether naïve CD4+ T cells might be of regulatory
phenotype and nature in the CNS, and could therefore
provide an opportunity for a novel therapeutic approach
in MS or other autoimmune diseases.
However, in order to develop new treatment strate-
gies, it is essential to understand how CNS tissue itself
regulates naïve T cell trafficking. In lymphoid tissue it is
known that T cell motility is directed by fibroblastic
reticular cells and ECM structures [23]. Similar reticular
structures exist in peripheral tissues such as the liver or
skin, but are absent from the non-inflamed brain
[27-29]. The source of the ECM structures in the CNS
during inflammatory conditions we could detect in this
study, however, is unclear. The ECM seems to undergo
significant structural changes in the CNS since we could
only detect SHG structures under inflammatory condi-
tions. Similarly, Wilson et al. showed a reticular fiber
network the produces a SHG signal during Toxoplasma
gondii infection [29]. SHG generated by excitation at
850 nm - EGFP 1110 nm -SHG merge
0 min                5 min                   10 min               15 min                   20 min 
C D
A
E
B
Figure 5 The role of inflammatory induced reticular fibers in naïve T cell migration in healthy and inflamed CNS tissue. (A) Intravital
TPLSM reveals inflammation induced reticular fibers which are visualised by second harmonic generation (SHG) at 1110 nm wavelength in the
brain stem of EAE affected mice. Naïve T cells partially migrate along SHG structures as demonstrated by cell tracks represented by white arrows
exemplarily. For further details see also Additional File 3. (B) To quantify SHG signal and naïve T cell interactions we analyse the co-localisation
area of SHG signal (blue) and tdRFP (red). The calculated colocalisation channel (white) was analyzed by determining the duration and the
velocity of the tracked contacts (scale bar 10 μm). (C) Interaction patterns were differentiated into short (less than 5 min duration) and long-
lasting contacts (equal or longer than 5 min duration,), Most of the contacts were short (79% ± 6; N = 164; white bar) but also long-lasting
interactions could be detected (20 ± 6%; N = 38; gray bar) and that these long-lasting contacts are due to migration associated co-localisation
as their velocity is > 0.04 μm/s. Data from two independent experiments are shown as percentage of all contacts (± SD). (D) Visualization of the
vasculature by IV injection of Rhodamine-dextrane prior to imaging enabled the visualisation of both, the reticular structures (green) and vessels
(red), simultaneously revealing that besides the vessel associated SHG signal a large amount of fibers originates directly from the CNS
parenchyma outside the perivascular space. 1 unit = 15 μm (E) Intravital TPLSM on brain stem of EAE affected C57BL/6 Thy1.1 CerTN L15 mice
which express a FRET based calcium sensor. The Citrulin/Cerulean FRET pair is expressed in neurons and is detected by excitation at 850 nm
(left, red) whereas SHG signal was generated by a separated excitation at 1110 nm (middle, green), which does not allow to detect either
Citrulin or Cerulean. Images are presented in false colors in order to increase the contrast between both separately detected structures. Merge of
both images derived from different excitation modes in the same layer demonstrates that the SHG signal (green) is not co-localised to neuronal
structures (red). These images are derived form the same layer at a depth of 60 μm below the surface. Scale bar 30 μm.
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Page 9 of 12wavelengths of 1000-1500 nm in TPLSM has its origin
from highly-ordered, non-centrosymmetric structures
such as collagen [30]. As the SHG phenomenon gives
no indication of the molecular nature of the structures,
it remains unclear which fibers are generating this sig-
nal. In the study of Wilson et al. the SHG signal was
co-localised with GFAP expressing astrocytes, but with a
spatial separation, suggesting that the SHG signal origi-
nates from extracellular fiber networks [29]. Further-
more, they found no increased collagen type IV or type
I induction but reticular structures by histology which
co-localised with CCL21 under inflammatory conditions,
suggesting that CCL21 could be one possible candidate,
because it is also known that impaired neurons bind
CCL21 on their surface [31]. However, as we investi-
gated the co-localisation of neuronal structures and the
SHG signal in EAE in transgenic mice expressing EGFP
or Citrulin under the neuron specific Thy1 promoter,
we could not detect any co-localisation. In contrast, we
observed an orthogonal crossing of neuronal structures
by the SHG signals, indicating that these structures are
not generated by intermediate filaments inside axons or
extra cellular matrix co-localised with axons in vivo.
Nevertheless, CCL21 bound to these reticular fibers,
could be a signal for attracting naïve T cells: Woolf et
al. compared soluble vs. matrix-bound CCL21 in an in
vitro assay and showed that naïve T cells migrated only
if the chemokine was matrix-bound [32]. Our experi-
ments are consistent with these results and demonstrate
in vivo relevance of the described phenomenon. Further-
more, our observations suggest that reticular fibers, ana-
logous to those of the lymph node’sE C M ,m a yp r o v i d e
a scaffold that supports T cell migration in the inflamed
brain.
5. Conclusions
The mechanisms of autoimmunity and tolerance in the
brain are still not clear and the role of naïve T cells as
possible key players in these complex processes is highly
debated [33]. Due to methodological limitations in the
past, there remains an ongoing discussion as to what
extent naïve T cells enter the healthy non-inflamed ver-
sus the inflamed CNS parenchyma and what role they
might have. For activated T cells, proteolytic enzymes
like metalloproteinases, disintegrins or granzymes are
known to enable migration through the inflamed brain
tissue [12,34,35]. These enzymes may be even more
important if the reticular fiber network is not as abun-
dant, as it is the case under inflammatory conditions
where it facilitates immune cell trafficking. In contrast
naïve T cells express molecules that are important for
migration to secondary lymphoid organs such as L-
Selectin and CCR7 for CD4+ T cells [36]. So it was
previously thought that they circulate between blood
and secondary lymphoid organs exclusively [37,38].
With the opportunity of TPLSM and the availability of
various fluorescent protein expressing transgenic mouse
models, we are now able to directly visualise the pre-
sence and dynamic processes of different T cell subsets
deep in CNS tissue in living animals. We show here that
the activation status rather than the T cell phenotype
and antigen specificity is the central requirement for the
migratory capacity of T cells in healthy CNS tissue inde-
pendent of transmigration-associated molecular interac-
tions at the blood brain barrier. Even though naïve T
cells show a high migratory capacity in lymphoid organs,
it remains to be seen why they appear in inflamed CNS
where they partially migrated along inflammation-
induced extracellular SHG structures and which signals
might be responsible for the observed high motility in
diseased brain tissue of EAE affected mice.
Although further studies are required to define the
composition of these reticular networks, targeting these
structures might be a novel therapeutic approach to
manage T cell-mediated inflammatory central nervous
system diseases.
Additional material
Additional file 1: Naïve T cells do not migrate into healthy CNS
tissue in vivo. Time lapse movie of naïve tdRFP expressing OT2 T cells
30 min after local application on the brain stem of a healthy mouse.
Additional file 2: Movement of naïve T cells in the brain stem
during EAE. Timelapse movie of naïve EGFP expressing OT-2 T cells in
the brain stem at peak of disease. Cells were MACS sorted for CD4 and
CD62L and transferred intravenously to EAE affected mice at peak of
disease. Analysis was performed 12 h after transfer.
Additional file 3: SHG structures are induced in the inflamed CNS
and naïve T cells partially migrate along these structures. Timelapse
movie of naïve EGFP expressing OT-2 T cells at peak of disease. Cells
were MACS sorted for CD4 and CD62L and transferred intravenously to
EAE affected mice at peak of disease. Analysis was performed 12 h after
transfer. Second harmonic generated signal was also detected in the
535/50 nm PMT and is displayed as a reticular structure.
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